Chargement en cours...
Targeted IgE Therapy for Patients With Moderate to Severe Asthma
It is well established that the proinflammatory cytokine immunoglobulin E (IgE) is a primary contributor to development of allergic airway inflammation following allergen exposure. Recent data suggest that blocking the effects of IgE with omalizumab, a recombinant DNA-derived humanized monoclonal an...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioCommunications LLC
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564312/ https://ncbi.nlm.nih.gov/pubmed/23390386 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|